Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2026-01-23

Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster

Endpoints News 2026-01-23

Lilly was the only pharma bidder for Ventyx

Endpoints News 2026-01-23

Insurance CEOs defend their businesses at House hearing

Endpoints News 2026-01-23

Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO

Endpoints News 2026-01-22

High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’

Endpoints News 2026-01-22

Drugmakers spent less on Washington lobbying in 2025's final quarter

Endpoints News 2026-01-22

Corcept's drug extends patients' lives in key ovarian cancer study

Endpoints News 2026-01-22

China-founded pharma Corxel raises up to $287M for oral GLP-1

Endpoints News 2026-01-22

Health insurance CEOs head to DC

Endpoints News 2026-01-22

Roche boosts NC factory investment to $2B; Rentschler CEO steps down

Endpoints News 2026-01-22

Another biopharma tried buying Amicus before BioMarin's $4.8B deal

Endpoints News 2026-01-22

Bristol Myers signs deal with Janux on T cell engager for $50M upfront

Endpoints News 2026-01-22

Erasca, Corvus, BioAge target $500M+ offerings

Endpoints News 2026-01-21

The status of EU drug price talks depends on who you ask

Endpoints News 2026-01-21

J&J praises new FDA guidance to speed development of multiple myeloma drugs

Endpoints News 2026-01-21

Johnson & Johnson brushes off MFN impact, sees strong growth for 2026

Endpoints News 2026-01-21

Tanabe pill delays blood disorder; enGene adds up to $100M from loans

Endpoints News 2026-01-21

IntraBio says rare disease drug passes Phase 3, will seek FDA approval

Endpoints News 2026-01-21

#JPM26: Regeneron, Lilly, Summit on rivals crowding into same targets

Endpoints News 2026-01-21

Exclusive: Claim Health raises $4.4M to help home care providers get paid

-51 / 23